Powder: -20°C for 3 years | In solvent: -80°C for 1 year
IMMH 010 maleate (YPD-30 maleate) is an orally available programmed cell death ligand 1 inhibitor with potential antitumor activity for the study of neurological disorders and advanced malignant solid tumors.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 195.00 | |
5 mg | In stock | $ 483.00 | |
10 mg | In stock | $ 692.00 | |
25 mg | In stock | $ 1,080.00 | |
50 mg | In stock | $ 1,490.00 | |
100 mg | In stock | $ 1,970.00 |
Description | IMMH 010 maleate (YPD-30 maleate) is an orally available programmed cell death ligand 1 inhibitor with potential antitumor activity for the study of neurological disorders and advanced malignant solid tumors. |
In vitro | IMMH-010 maleate (YPD-30) is an ester prodrug of YPD-29B, which is an effective small-molecule inhibitor targeting hPD-L1 in vitro[1]. |
In vivo | IMMH-010 maleate (YPD-30; 2.5, 5, and 10 mg/kg; oral administration, twice weekly) significantly delayed tumor progression in mice compared to the vehicle group in a dose-dependent manner. The tumor growth inhibition rates (TGI) were 40.5% (2.5 mg/kg), 60.9% (5 mg/kg), and 67.9% (10 mg/kg), respectively[1]. |
Synonyms | YPD-30 maleate |
Molecular Weight | 756.04 |
Formula | C36H36BrClN2O9 |
CAS No. | 2541982-47-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
IMMH 010 maleate 2541982-47-0 Apoptosis Cell Cycle/Checkpoint Immunology/Inflammation PD-1/PD-L1 YPD-30 maleate IMMH010maleate inhibitor inhibit